A detailed history of Commonwealth Equity Services, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 30,000 shares of AURA stock, worth $266,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,000
Previous 25,000 20.0%
Holding current value
$266,700
Previous $189,000 41.27%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$6.9 - $10.36 $34,500 - $51,800
5,000 Added 20.0%
30,000 $267,000
Q2 2024

Jul 31, 2024

BUY
$6.81 - $7.89 $170,250 - $197,250
25,000 New
25,000 $189,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $260M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.